Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.
about
Biocompatible dialysis fluids for peritoneal dialysisEffect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-AnalysisIncreasing the use of biocompatible, glucose-free peritoneal dialysis solutionsChanges in the worldwide epidemiology of peritoneal dialysis.The Current State of Peritoneal DialysisEffect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trials.Baseline serum interleukin-6 predicts cardiovascular events in incident peritoneal dialysis patients.Relative survival of peritoneal dialysis and haemodialysis patients: effect of cohort and mode of dialysis initiation.Improving survival rate of Korean patients initiating dialysisUtility of Urinary Biomarkers in Predicting Loss of Residual Renal Function: The balANZ TrialPredictors of residual renal function decline in patients undergoing continuous ambulatory peritoneal dialysisBaseline hydration status in incident peritoneal dialysis patients: the initiative of patient outcomes in dialysis (IPOD-PD study)†A review of acute and chronic peritoneal dialysis in developing countriesIs It Beneficial to Convert to a Neutral-pH Bicarbonate/Lactate-Buffered PD Solution in Long-Term CAPD Patients? A Single-Center Prospective Study.Association between serum leptin levels and peritoneal dialysis: A meta-analysis.The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial.ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors.Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis.The balANZ study--strengthening the evidence for neutral-pH solutions low in glucose degradation productsThe effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial.Balance about balANZ.Trials (and tribulations) of biocompatible peritoneal dialysis fluidsEffect of Icodextrin Solution on the Preservation of Residual Renal Function in Peritoneal Dialysis Patients: A Randomized Controlled StudyAssociation of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomesDialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients.Biocompatible peritoneal dialysis fluids: clinical outcomes.Peritoneal dialysis--current status and future challenges.Strategies for the preservation of residual renal function in pediatric dialysis patients.Pharmacologic targets and peritoneal membrane remodeling.Difficult peritonitis cases in children undergoing chronic peritoneal dialysis: relapsing, repeat, recurrent and zoonotic episodes.Strategies for preserving residual renal function in peritoneal dialysis patientsPreserving the peritoneal membrane in long-term peritoneal dialysis patients.The Use of Incremental Peritoneal Dialysis in a Large Contemporary Peritoneal Dialysis Program.Peritoneal dialysis practice in Australia and New Zealand: A call to sustain the action.Peritoneal dialysis-related infections recommendations: 2016 update. What is new?The Association Between Glucose Exposure and the Risk of Peritonitis in Peritoneal Dialysis Patients.Effect of benfotiamine in podocyte damage induced by peritoneal dialysis fluid."Biocompatible" Neutral pH Low-GDP Peritoneal Dialysis Solutions: Much Ado About Nothing?Is there such a thing as biocompatible peritoneal dialysis fluid?Higher Dialysate Matrix Metalloproteinase-2 Levels Are Associated with Peritoneal Membrane Dysfunction.
P2860
Q24197836-A6B1BC16-66DF-4951-8097-5576163E14F9Q26852444-A9CCAADB-0154-4008-9757-F186FB928D48Q28082263-DA46091E-2FA2-4513-8118-C655132CAF87Q30239926-985F4437-0A7C-421A-9E7F-B834AF7069BFQ30243902-C817A318-E312-47DB-B8FF-7DE84DD631DBQ34725102-F445BEF1-F591-44D3-93EB-054E7D916B1EQ35106066-3A6FC79A-B790-4EDB-AD85-10FD4B85E73EQ35116424-FE2DD121-0E8F-4379-8916-BAAD0F17A297Q35421557-7E438A00-E76A-4A68-B233-B723F0B3EC5EQ35524711-263185E9-ACEB-4CA9-83BB-F704AE9126D4Q35524742-DDCA2753-D27C-4719-B47B-0C217EEF33DFQ35587014-03058CD1-C5E9-468B-B100-1391D8ECBD85Q35633466-6ECA36E0-1789-4683-81B9-ABEBB77BF77EQ35647496-FB67B6ED-69BD-4AA7-9EFC-895611EE31C2Q35690271-E150869E-4450-4486-B2ED-E95D0D28F4E8Q35824659-FA6B81D3-066D-400B-9E1E-B9CB7081D573Q35904398-763FBD60-1C0C-4C77-AD42-D0D399060A97Q36022479-A200BA9D-D0E9-4EED-8C89-321EA4F59900Q36474231-6006F324-8D0B-4208-A580-47A15F8A9C36Q36474236-5D01B4DB-A4F6-44C2-804E-69C4D7C4600AQ36474255-A00AF2DE-06E9-42D6-8DEF-D842EE0C96EFQ36475670-EC710759-55E0-47D9-AA60-CEFD94CB64A6Q37205850-E3B0CCB2-BB46-4685-B502-71EBC1AFE429Q37247002-CC9EA8E1-F00C-4286-813E-2D7107D4B18CQ37485572-F3BEDF7E-0FE3-4886-92DB-4B71C10F18A0Q38068420-685A59A1-4E25-4BC0-89C1-6B0212EF39A5Q38108108-BECE889F-7397-4744-9FB9-C950EC8E78ACQ38122625-DF369A35-910E-45BD-8A91-38B217B3494CQ38187841-87905470-6B82-45AB-A1C6-6A63FE3E128AQ38251157-FD980E68-16A3-47B6-A0BF-7198DC463849Q38393215-38EBD283-A5A6-4BC7-8B20-25110C61D8A4Q38568149-1EC5DFAC-0A07-4A35-9B5C-53AF346076C9Q38637895-CA123482-8A54-464C-A0A0-DA1DE5001151Q38710566-9C29F168-CDCD-4DF6-B4BE-45008F5126BFQ38749549-BF22D4F6-C1A4-4623-9416-D9526F46ED30Q38798159-5D09AB46-67B2-40F0-8446-658945648880Q38895522-D0CD3BB4-A9B6-479E-9E6B-39CC562B7425Q38934145-E63D1D4B-ABF4-4FCA-80C3-468A9CB50588Q38976940-A8E71656-2AD7-46FD-AF34-73362EF8522FQ39117321-64562CE8-4430-4BE2-851E-78A650ACF1F8
P2860
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.
@ast
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.
@en
type
label
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.
@ast
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.
@en
prefLabel
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.
@ast
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.
@en
P2093
P2860
P356
P1476
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes
@en
P2093
Bernard Jones
David Voss
Dwarakanathan Ranganathan
Fiona G Brown
John Schollum
Margaret Clarke
Marjorie W Y Foo
Michael Suranyi
Neil Boudville
Robyn Langham
P2860
P304
P356
10.1681/ASN.2011121201
P577
2012-03-22T00:00:00Z